| SAREPTA THERAP. DL-,0001 | 
| USA | 
| Gesundheit | 
| US8036071004 / A1J1BH | 
| AB3A (Frankfurt) / SRPT (NASDAQ) | 
| FRA:AB3A, ETR:AB3A, AB3A:GR, NASDAQ:SRPT | 
| - | 
| https://www.sarepta.com/ | 
| 
            Sarepta Therapeutics Inc. is a biopharmaceutical c..
             >Volltext..  | 
      
| 2036.74 Mio. EUR | 
| 2508.78 Mio. EUR | 
| 2154.31 Mio. EUR | 
| 48.88 Mio. EUR | 
| -50.31 Mio. EUR | 
| -0.51 EUR | 
| 1175.35 Mio. EUR | 
| 443.27 Mio. EUR | 
| -261.1 Mio. EUR | 
| 0.87 | 
| 49.93% | 
| -211.42% | 
| - | 
| - | 
| - | 
| - | 
| SAREPTA, AVI BIOPHARMA | 
| 04.11.25 | 
      
  | 
||||
      
  |